Dermatomyositis Associated with Lung Cancer: A Brief Review of the Current Literature and Retrospective Single Institution Experience

被引:5
作者
Shalata, Walid [1 ]
Zolnoorian, Jeremy [2 ]
Meirovitz, Amichay [1 ]
Sheva, Kim [1 ]
Jama, Ashraf Abu [1 ]
Saleh, Omar Abu [3 ]
Yakobson, Alexander [1 ]
机构
[1] Ben Gurion Univ Negev, Legacy Heritage Ctr & Larry Norton Inst, Soroka Med Ctr, IL-84105 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Med Sch Int Hlth, IL-84105 Beer Sheva, Israel
[3] Emek Med Ctr, Dept Dermatol & Venereol, IL-18341 Afula, Israel
来源
LIFE-BASEL | 2023年 / 13卷 / 01期
关键词
dermatomyositis; lung cancer; paraneoplastic syndrome; dermal toxicity; IDIOPATHIC INFLAMMATORY MYOPATHIES; POLYMYOSITIS; MALIGNANCY; EGFR; CLASSIFICATION; MANIFESTATION; PROGNOSIS; DISEASE; PATIENT; ADULT;
D O I
10.3390/life13010040
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Dermatomyositis is a rare inflammatory myopathy that is often related to lung cancer. In this retrospective observational study, we analyzed data from patients diagnosed with lung cancer at Soroka University Medical Center between January 2017 and July 2021. A total of 689 patients with lung cancer were included in this study, 97 of whom had small cell lung cancer and 592 had non-small cell lung cancer. We identified a single patient (60-year-old female) who presented with signs and symptoms of dermatomyositis, which was later confirmed to be associated with lung cancer as a paraneoplastic syndrome. Both our study and a recent review of the literature illustrate the temporal link between dermatomyositis and lung cancer, as well as reinforce the need for heightened cancer screenings in DM patients.
引用
收藏
页数:15
相关论文
共 52 条
  • [1] Malignancy in Myositis
    Abou Zahr, Zaki
    Baer, Alan N.
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (03) : 208 - 215
  • [2] Prognosis and mortality of polymyositis and dermatomyositis patients
    Airio, A
    Kautiainen, H
    Hakala, M
    [J]. CLINICAL RHEUMATOLOGY, 2006, 25 (02) : 234 - 239
  • [3] [Anonymous], 2013, Tobacco
  • [4] Arnon J., 2021, JTO CLIN RES REP, V2, DOI [10.1016/j.jtocrr.2021.100217, DOI 10.1016/J.JTOCRR.2021.100217]
  • [5] BARNES BE, 1976, ANN INTERN MED, V84, P68, DOI 10.7326/0003-4819-84-1-68
  • [6] Bendewald MJ, 2010, ARCH DERMATOL, V146, P26, DOI 10.1001/archdermatol.2009.328
  • [7] Incidence of malignant disease in biopsy-proven inflammatory myopathy - A population-based cohort study
    Buchbinder, R
    Forbes, A
    Hall, S
    Dennett, X
    Giles, G
    [J]. ANNALS OF INTERNAL MEDICINE, 2001, 134 (12) : 1087 - 1095
  • [8] Paraneoplastic dermatomyositis associated with adenocarcinoma of the lung
    Bursac, Daliborka S.
    Sazdanic-Velikic, Danica S.
    Tepavac, Aleksandar P.
    Secen, Nevena M.
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (03) : 730 - 732
  • [9] Driven by by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non-Small Cell Lung Cancer
    Castellanos, Emily
    Feld, Emily
    Horn, Leora
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (04) : 612 - 623
  • [10] Catino A., 2021, J THORAC ONCOL, DOI [10.1016/j.jtho.2021.01.1175, DOI 10.1016/J.JTHO.2021.01.1175]